Suppr超能文献

成釉细胞瘤中肿瘤侵袭性的分子标志物:最新进展

Molecular markers of tumor invasiveness in ameloblastoma: An update.

作者信息

Zhong Yi, Guo Wei, Wang Li, Chen Xinming

机构信息

Department of Oral and Maxillofacial Surgery, Nineth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology, Shanghai, Peoples Republic of China.

出版信息

Ann Maxillofac Surg. 2011 Jul;1(2):145-9. doi: 10.4103/2231-0746.92780.

Abstract

The aim of the present article was to review the current new knowledge on the molecular markers of tumor invasion in ameloblastoma. In this review, tumor molecular markers were identified and allocated to the following six groups according to their functions: (I) Markers involved in extracellular matrix degradation, (II) Molecular markers involved in cell adhesion lost, (III) Molecular markers involved in bone remodeling, (IV) Cytokines involved in angiogenesis, (V) Molecular markers related with the function of tumor stromal cells on the invasion of ameloblastoma, and (VI) Molecular markers involved in cell proliferation related with invasion. In general, the location of markers within the tumor and not their quantitative assessments as such is emphasized. Data showed that the correlation among molecular markers of invasive relevance is still not quite clear. Results on markers of tumor invasion and metastatic potential appeared to be too premature for a statement regarding the instinct invasive nature of ameloblastoma. The unraveling of specific new details concerning these mechanisms, whereby the expression and relationships among the molecules are mediated, may provide an opportunity to afford efficient prevention and develop new treatment therapies.

摘要

本文的目的是综述成釉细胞瘤中肿瘤侵袭分子标志物的当前新知识。在本综述中,肿瘤分子标志物根据其功能被识别并分为以下六组:(I)参与细胞外基质降解的标志物,(II)参与细胞黏附丧失的分子标志物,(III)参与骨重塑的分子标志物,(IV)参与血管生成的细胞因子,(V)与肿瘤基质细胞对成釉细胞瘤侵袭功能相关的分子标志物,以及(VI)与侵袭相关的细胞增殖相关分子标志物。一般来说,强调的是标志物在肿瘤内的位置而非其定量评估。数据表明,具有侵袭相关性的分子标志物之间的相关性仍不太清楚。关于肿瘤侵袭和转移潜能标志物的结果对于就成釉细胞瘤的固有侵袭性作出陈述而言似乎还为时过早。阐明有关这些机制的具体新细节,即分子之间的表达和关系是如何介导的,可能会提供一个进行有效预防和开发新治疗方法的机会。

相似文献

1
Molecular markers of tumor invasiveness in ameloblastoma: An update.
Ann Maxillofac Surg. 2011 Jul;1(2):145-9. doi: 10.4103/2231-0746.92780.
2
Prognostic relevance of molecular markers of oral cancer--a review.
Int J Oral Maxillofac Surg. 2003 Jun;32(3):233-45. doi: 10.1054/ijom.2002.0383.
3
Molecular markers of cell adhesion in ameloblastomas. An update.
Med Oral Patol Oral Cir Bucal. 2014 Jan 1;19(1):e8-e14. doi: 10.4317/medoral.19071.
4
Review article: Current concepts of ameloblastoma pathogenesis.
J Oral Pathol Med. 2010 Sep;39(8):585-91. doi: 10.1111/j.1600-0714.2010.00908.x. Epub 2010 Jul 2.
5
Surface vacuolar ATPase in ameloblastoma contributes to tumor invasion of the jaw bone.
Int J Oncol. 2016 Mar;48(3):1258-70. doi: 10.3892/ijo.2016.3350. Epub 2016 Jan 19.
6
Inhibition of ameloblastoma invasion in vitro and in vivo by inhibitor of metalloproteinase-2 activity.
J Oral Pathol Med. 2009 Oct;38(9):731-6. doi: 10.1111/j.1600-0714.2009.00771.x. Epub 2009 Mar 24.
7
Expression of molecules related to AKT pathway as putative regulators of ameloblastoma local invasiveness.
J Oral Pathol Med. 2014 Feb;43(2):143-7. doi: 10.1111/jop.12103. Epub 2013 Jul 10.
8
RECK overexpression reduces invasive ability in ameloblastoma cells.
J Oral Pathol Med. 2014 Sep;43(8):613-8. doi: 10.1111/jop.12179. Epub 2014 Mar 20.
9
Fibroblasts promote the collective invasion of ameloblastoma tumor cells in a 3D coculture model.
FEBS Open Bio. 2017 Nov 2;7(12):2000-2007. doi: 10.1002/2211-5463.12313. eCollection 2017 Dec.
10
Invadopodia proteins, cortactin, N-WASP and WIP differentially promote local invasiveness in ameloblastoma.
J Oral Pathol Med. 2016 Sep;45(8):591-8. doi: 10.1111/jop.12417. Epub 2016 Jan 11.

引用本文的文献

1
Immunohistochemical Expression of Ki-67 and p53 and Their Prognostic Role in Ameloblastoma: A Longitudinal Study.
Oman Med J. 2024 Mar 31;39(2):e607. doi: 10.5001/omj.2024.55. eCollection 2024 Mar.
2
Identification of Molecular Mechanisms of Ameloblastoma and Drug Repositioning by Integration of Bioinformatics Analysis and Molecular Docking Simulation.
Bioinform Biol Insights. 2024 May 28;18:11779322241256459. doi: 10.1177/11779322241256459. eCollection 2024.
3
Intercellular signaling between ameloblastoma and osteoblasts.
Biochem Biophys Rep. 2022 Feb 18;30:101233. doi: 10.1016/j.bbrep.2022.101233. eCollection 2022 Jul.
4
MAID chemotherapy regimen as a treatment strategy for metastatic malignant ameloblastoma: A case report.
Medicine (Baltimore). 2019 Jun;98(25):e15873. doi: 10.1097/MD.0000000000015873.
5
Immunohistochemical expression of osteonectin, matrix metalloproteinases-9 and Ki-67 in ameloblastoma.
J Oral Maxillofac Pathol. 2018 Sep-Dec;22(3):446. doi: 10.4103/jomfp.JOMFP_271_17.
6
Amelogenin is a Potential Biomarker for the Aggressiveness in Odontogenic Tumors.
Asian Pac J Cancer Prev. 2018 May 26;19(5):1375-1379. doi: 10.22034/APJCP.2018.19.5.1375.
7
Immunohistochemistry of Five Molecular Markers for Typing and Management of Ameloblastomas: A Retrospective Analysis of 40 Cases.
J Maxillofac Oral Surg. 2017 Mar;16(1):65-70. doi: 10.1007/s12663-016-0923-5. Epub 2016 Jun 2.
8
Odontogenic tumor markers - an overview.
J Int Oral Health. 2013 Apr;5(2):59-69.
9
Molecular markers of cell adhesion in ameloblastomas. An update.
Med Oral Patol Oral Cir Bucal. 2014 Jan 1;19(1):e8-e14. doi: 10.4317/medoral.19071.

本文引用的文献

1
Expression of osteonectin/secreted protein acidic and rich in cysteine and matrix metalloproteinases in ameloblastoma.
J Oral Pathol Med. 2010 Mar;39(3):242-9. doi: 10.1111/j.1600-0714.2009.00862.x. Epub 2010 Jan 11.
2
WNT5A expression in ameloblastoma and its roles in regulating enamel epithelium tumorigenic behaviors.
Am J Pathol. 2010 Jan;176(1):461-71. doi: 10.2353/ajpath.2010.090478. Epub 2009 Dec 11.
3
Expression of RECK and matrix metalloproteinase-2 in ameloblastoma.
BMC Cancer. 2009 Dec 8;9:427. doi: 10.1186/1471-2407-9-427.
4
Expression and role of metalloproteinase-2 and endogenous tissue regulator in ameloblastoma.
J Oral Pathol Med. 2010 Mar;39(3):219-22. doi: 10.1111/j.1600-0714.2009.00827.x. Epub 2009 Aug 26.
5
Expression of Twist in different subtype of ameloblastomas.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Oct;108(4):565-70. doi: 10.1016/j.tripleo.2009.05.041. Epub 2009 Aug 20.
6
Enhanced expression of podoplanin in ameloblastomas.
J Oral Pathol Med. 2010 Jan;39(1):103-9. doi: 10.1111/j.1600-0714.2009.00818.x. Epub 2009 Aug 18.
7
Expression of transforming growth factor beta1 in ameloblastomas.
J Craniofac Surg. 2008 Nov;19(6):1618-21. doi: 10.1097/SCS.0b013e318188a2cd.
9
Stromal cells promote bone invasion by suppressing bone formation in ameloblastoma.
Histopathology. 2008 Oct;53(4):458-67. doi: 10.1111/j.1365-2559.2008.03127.x.
10
Expression of osteopontin and its receptors in ameloblastomas.
Oral Oncol. 2009 Jun;45(6):538-42. doi: 10.1016/j.oraloncology.2008.07.015. Epub 2008 Sep 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验